Pharmaceutical compositions comprising {4 - (5 - fluoro - 2.4 - 7 - amino - 1,4 - dihydro - 2H - quinazolin - 3 - yl) - phenyl) - 5 - Chloro - thiophen-2-yl - sulfonylurea or salts thereof for the inhibition of platelet aggregation induced by ADP

摘要

1. Inhibition of platelet aggregation induced by ADP when needed by human subjects; This method includes injecting a drug ingredient into a subject, including a formula compound, and an acceptable precursor chemical or vehicle on at least one drug, and indicating the ingredient for intravenous injection. 2. Claim method 1. A method of inhibiting platelet aggregation, induced by ADP, to be needed by a human subject,This method involves injecting a drug ingredient into the subject, including a formula compound:The composition of the compound is a unit dose containing 1 to 50 mg of the compound. 3. - the second recovery method, with a unit dose of 5 to 40 mg of the compound. 4. - the third recovery method, unit dose from 10 to 30 mg. 5. - the fourth recovery method, with a unit dose of 15 to 25 mg of the compound. 6. - the fifth recovery method, the unit dose is about 20 mg of the compound.